ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0585

Predictors of Health-Related Quality of Life in Rheumatoid Arthritis Patients

Nejat Hassen1, Yufei Zheng2, Hui Xie2, Karim Khan3, Jacek Kopec4 and Diane Lacaille2, 1University of British Columbia, Arthritis Research Canada, Richmond, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3University of British Columbia, Vancouver, BC, Canada, 4University of British Columbia, Richmond, BC, Canada

Meeting: ACR Convergence 2021

Keywords: quality of life, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Epidemiology & Public Health Poster II: Inflammatory Arthritis – RA, SpA, & Gout (0560–0593)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Health-related quality of life (HRQoL) is lower in rheumatoid arthritis (RA) patients compared to the general population, yet a comprehensive study evaluating predictors and the relative contribution of sociodemographic, RA-related, comorbidities, and lifestyle factors is lacking. Our study’s objectives were to identify factors that predict 1) HRQoL one year after baseline assessment; and 2) change in HRQoL over 12 months.

Methods: Survey data from a longitudinal quality of care study of RA patients recruited from a population-based cohort identified using administrative data were analysed. Participants who completed a questionnaire in 2015 and 2016 assessing sociodemographic, health status (RA-related and comorbidities), and lifestyle variables were included. The dependent variable HRQoL was measured using EQ5D-VAS. Three model selection procedures for multivariable linear regression models – stepwise selection (p-entry< 0.05;p-exit≥0.15), all-possible selection, and LASSO method – were used to select important HRQoL predictors. Models were compared using cross-validation (CV) and the model with smallest CV error was selected. Model selections without and with 2015 EQ5D-VAS, in separate analyses, were conducted to determine best models for absolute value-, and change in HRQoL, respectively. We used R2 to assess the variance explained by each model and to determine the relative contributions of sociodemographic, RA-related, comorbidities, and lifestyle factors (sum of R2 values for each domain). Data analyses were conducted using RStudio 1.3.1093.

Results: Our sample included 168 individuals with RA (72% women, mean age 70.7 ± 10.6 years, mean disease duration 24.3 ± 11.9 years). EQ5D-VAS in 2016 was 67.5/100 ± 19.4. Significant predictors and variance explained by models without, and with, 2015 HRQoL are presented in Tables 1 and 2, respectively. The model controlling for baseline 2015 HRQoL had a lower AIC and better predictive ability (R2 value) for 2016 HRQoL. HRQoL in the previous year contributed most to predicting HRQoL. Of the RA-related factors, only disease activity and physical function (in models with, and without, 2015-HRQoL) were significant predictors. Both variables were highly correlated (r=0.69) and likely capture similar disease effects. Of the comorbidities evaluated, only depression predicted HRQoL, and it had a greater contribution to HRQoL than RA-related factors. Lifestyle and sociodemographic factors evaluated in our study contributed little to HRQoL.

Our study limitations include potential respondent bias and a predominantly White and older sample with longstanding disease. Our findings may not be generalizable to samples with different characteristics.

Conclusion: HRQoL in our RA sample was multifactorial. Predictors from different domains contributed to HRQoL. HRQoL in the previous year contributed most to predicting future HRQoL. Depression was the second most important predictor. Early identification and management of depression may improve overall HRQoL in RA patients.


Disclosures: N. Hassen, None; Y. Zheng, None; H. Xie, None; K. Khan, None; J. Kopec, None; D. Lacaille, None.

To cite this abstract in AMA style:

Hassen N, Zheng Y, Xie H, Khan K, Kopec J, Lacaille D. Predictors of Health-Related Quality of Life in Rheumatoid Arthritis Patients [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/predictors-of-health-related-quality-of-life-in-rheumatoid-arthritis-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/predictors-of-health-related-quality-of-life-in-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology